Payment overview · 2025
General Payments
$840.59
13 reported records · 5 companies
Healthcare provider profile · identity verified
Navin Choudhary, MD
Allopathic & Osteopathic Physicians|Internal Medicine · SAINT LOUIS, MO · NPI 1104913896
Verified facts
What the public records show
CMS Open Payments records show Navin Choudhary, MD received $840.59 in general payments during 2025 across 13 reported records.
Vanda Pharmaceuticals Inc. accounted for 44.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 10 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Abrysvo.
Amgen Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PROLIA as an associated drug or biological on 20867 records involving 11744 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Prolia by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ABRYSVO as an associated drug or biological on 55380 records involving 31565 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Abrysvo by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 347 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $374.98 | 44.6% | 3 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $219.42 | 26.1% | 3 | 2025 |
| Eisai Inc. | Unresolved — no canonical attribution shown | $150.25 | 17.9% | 2 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $77.79 | 9.2% | 4 | 2025 |
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $18.15 | 2.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $840.59 | 13 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $374.98 | 3 | 2025 |
Source payment records
|
|||||
| Leqembi Normalized: leqembi |
Drug | Eisai Inc. | $150.25 | 2 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $126.05 | 2 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $98.78 | 2 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $64.26 | 3 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $64.26 | 3 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $64.26 | 3 | 2025 |
Source payment records
|
|||||
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $18.15 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $13.53 | 1 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $13.53 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| ABRYSVO abrysvo |
2025 | Abrysvo | 2024 | 23 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Amgen Inc. Exact reporting entity; no affiliate inference |
2025 | PROLIA open payments reported associated product |
CMS Open Payments — General Payments 20867 supporting records · 11744 recipient NPIs · example record 1226874448 |
Prolia · 2024 Exact normalized brand match · 1 Part D row |
22 | 15 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ABRYSVO open payments reported associated product |
CMS Open Payments — General Payments 55380 supporting records · 31565 recipient NPIs · example record 1228794147 |
Abrysvo · 2024 Exact normalized brand match · 1 Part D row |
23 | 23 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
347 | 74 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
22 | 22 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1099 | 232 |
| Levothyroxine Sodium | Levothyroxine Sodium | 988 | 194 |
| Amlodipine Besylate | Amlodipine Besylate | 908 | 201 |
| Tramadol Hcl | Tramadol Hcl | 777 | 169 |
| Alprazolam | Alprazolam | 711 | 133 |
| Lisinopril | Lisinopril | 681 | 149 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 640 | 105 |
| Pantoprazole Sodium | Pantoprazole Sodium | 620 | 139 |
| Gabapentin | Gabapentin | 617 | 129 |
| Losartan Potassium | Losartan Potassium | 531 | 110 |
| Furosemide | Furosemide | 520 | 130 |
| Trazodone Hcl | Trazodone Hcl | 484 | 96 |
| Omeprazole | Omeprazole | 452 | 106 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 449 | 91 |
| Metoprolol Tartrate | Metoprolol Tartrate | 413 | 87 |
| Metoprolol Succinate | Metoprolol Succinate | 399 | 85 |
| Metformin Hcl | Metformin Hcl | 392 | 99 |
| Duloxetine Hcl | Duloxetine Hcl | 375 | 75 |
| Donepezil Hcl | Donepezil Hcl | 372 | 51 |
| Memantine Hcl | Memantine Hcl | 370 | 48 |
| Clopidogrel | Clopidogrel Bisulfate | 350 | 65 |
| Eliquis | Apixaban | 347 | 74 |
| Sertraline Hcl | Sertraline Hcl | 334 | 72 |
| Escitalopram Oxalate | Escitalopram Oxalate | 332 | 62 |
| Potassium Chloride | Potassium Chloride | 331 | 73 |
| Mirtazapine | Mirtazapine | 310 | 58 |
| Simvastatin | Simvastatin | 308 | 61 |
| Tamsulosin Hcl | Tamsulosin Hcl | 295 | 64 |
| Zolpidem Tartrate | Zolpidem Tartrate | 287 | 42 |
| Meloxicam | Meloxicam | 281 | 53 |
| Lorazepam | Lorazepam | 273 | 70 |
| Carvedilol | Carvedilol | 272 | 57 |
| Clonazepam | Clonazepam | 222 | 34 |
| Warfarin Sodium | Warfarin Sodium | 216 | 33 |
| Quetiapine Fumarate | Quetiapine Fumarate | 210 | 41 |
| Pravastatin Sodium | Pravastatin Sodium | 205 | 47 |
| Buspirone Hcl | Buspirone Hcl | 202 | 47 |
| Citalopram Hbr | Citalopram Hydrobromide | 196 | 42 |
| Montelukast Sodium | Montelukast Sodium | 188 | 42 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 179 | 66 |
| Allopurinol | Allopurinol | 179 | 48 |
| Fluticasone Propionate | Fluticasone Propionate | 177 | 60 |
| Hydrochlorothiazide | Hydrochlorothiazide | 173 | 58 |
| Ozempic | Semaglutide | 172 | 37 |
| Jardiance | Empagliflozin | 162 | 36 |
| Spironolactone | Spironolactone | 153 | 36 |
| Famotidine | Famotidine | 151 | 37 |
| Glimepiride | Glimepiride | 150 | 42 |
| Xarelto | Rivaroxaban | 149 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 142 | 27 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 142 | 31 |
| Bupropion Xl | Bupropion Hcl | 139 | 37 |
| Farxiga | Dapagliflozin Propanediol | 139 | 27 |
| Hydralazine Hcl | Hydralazine Hcl | 130 | 28 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 128 | 47 |
| Pregabalin | Pregabalin | 127 | 24 |
| Ezetimibe | Ezetimibe | 123 | 29 |
| Celecoxib | Celecoxib | 119 | 21 |
| Ropinirole Hcl | Ropinirole Hcl | 117 | 23 |
| Alendronate Sodium | Alendronate Sodium | 110 | 31 |
| Myrbetriq | Mirabegron | 98 | 15 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 98 | 28 |
| Diazepam | Diazepam | 96 | 18 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 95 | 22 |
| Latanoprost | Latanoprost | 94 | 20 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 94 | 19 |
| Telmisartan | Telmisartan | 93 | 25 |
| Finasteride | Finasteride | 92 | 21 |
| Midodrine Hcl | Midodrine Hcl | 91 | 20 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 88 | 68 |
| Olanzapine | Olanzapine | 87 | 20 |
| Oxybutynin Chloride | Oxybutynin Chloride | 87 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 84 | 20 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 81 | 30 |
| Divalproex Sodium | Divalproex Sodium | 79 | 19 |
| Nystatin | Nystatin | 79 | 31 |
| Torsemide | Torsemide | 78 | 19 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 77 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 77 | 15 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 77 | 15 |
| Ibuprofen | Ibuprofen | 76 | 23 |
| Doxepin Hcl | Doxepin Hcl | 74 | 12 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 74 | 20 |
| Oxycodone Hcl | Oxycodone Hcl | 74 | 16 |
| Prednisone | Prednisone | 73 | 44 |
| Baclofen | Baclofen | 72 | 16 |
| Diclofenac Sodium | Diclofenac Sodium | 72 | 19 |
| Atenolol | Atenolol | 70 | 19 |
| Januvia | Sitagliptin Phosphate | 69 | 18 |
| Risperidone | Risperidone | 69 | 11 |
| Loperamide | Loperamide Hcl | 68 | 39 |
| Propranolol Hcl | Propranolol Hcl | 67 | 19 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 63 | 15 |
| Topiramate | Topiramate | 63 | 12 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 62 | 16 |
| Temazepam | Temazepam | 62 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 61 | 14 |
| Levetiracetam | Levetiracetam | 60 | 14 |
| Memantine Hcl Er | Memantine Hcl | 60 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 59 | 31 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 58 | 47 |
| Aripiprazole | Aripiprazole | 58 | suppressed |
| Lovastatin | Lovastatin | 56 | 16 |
| Bupropion Hcl | Bupropion Hcl | 54 | 11 |
| Lamotrigine | Lamotrigine | 54 | suppressed |
| Ondansetron Odt | Ondansetron | 54 | 21 |
| Amiodarone Hcl | Amiodarone Hcl | 53 | 19 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 52 | suppressed |
| Glipizide | Glipizide | 52 | 13 |
| Valsartan | Valsartan | 52 | 14 |
| Mounjaro | Tirzepatide | 51 | 13 |
| Digoxin | Digoxin | 50 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 50 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 50 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 50 | 38 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 48 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 48 | suppressed |
| Carbamazepine | Carbamazepine | 47 | suppressed |
| Entresto | Sacubitril/Valsartan | 46 | suppressed |
| Naproxen | Naproxen | 45 | 17 |
| Primidone | Primidone | 45 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 44 | suppressed |
| Mupirocin | Mupirocin | 44 | 27 |
| Pioglitazone Hcl | Pioglitazone Hcl | 44 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 43 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 43 | suppressed |
| Folic Acid | Folic Acid | 43 | suppressed |
| Synthroid | Levothyroxine Sodium | 43 | 11 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 40 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 39 | 14 |
| Doxycycline Hyclate | Doxycycline Hyclate | 39 | 33 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 38 | 24 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 37 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 37 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 37 | 17 |
| Diltiazem Hcl | Diltiazem Hcl | 36 | suppressed |
| Gemtesa | Vibegron | 36 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 35 | suppressed |
| Acyclovir | Acyclovir | 34 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 34 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 34 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 34 | 11 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 33 | suppressed |
| Amoxicillin | Amoxicillin | 32 | 19 |
| Valacyclovir | Valacyclovir Hcl | 32 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 31 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 31 | suppressed |
| Nystop | Nystatin | 31 | 18 |
| Azithromycin | Azithromycin | 30 | 28 |
| Benztropine Mesylate | Benztropine Mesylate | 30 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 30 | 28 |
| Fluconazole | Fluconazole | 30 | 25 |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 28 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 28 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 28 | suppressed |
| Estradiol | Estradiol | 27 | 11 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 27 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 27 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 26 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 26 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 26 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 26 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Cephalexin | Cephalexin | 25 | 19 |
| Ventolin Hfa | Albuterol Sulfate | 25 | 13 |
| Fenofibrate | Fenofibrate,micronized | 24 | suppressed |
| Olanzapine Odt | Olanzapine | 24 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 23 | 23 |
| Clobetasol Propionate | Clobetasol Propionate | 23 | 15 |
| Doxazosin Mesylate | Doxazosin Mesylate | 23 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 23 | suppressed |
| Novolog Flexpen | Insulin Aspart | 23 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 23 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 23 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 22 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 22 | 11 |
| Levofloxacin | Levofloxacin | 22 | 18 |
| Nortriptyline Hcl | Nortriptyline Hcl | 22 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 22 | 22 |
| Prolia | Denosumab | 22 | 15 |
| Ramipril | Ramipril | 22 | suppressed |
| Linzess | Linaclotide | 21 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 21 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Lorazepam Intensol | Lorazepam | 20 | 18 |
| Fenofibrate | Fenofibrate Nanocrystallized | 19 | suppressed |
| Methocarbamol | Methocarbamol | 19 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 19 | 19 |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Verapamil Er | Verapamil Hcl | 19 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 18 | 18 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | 12 |
| Eszopiclone | Eszopiclone | 18 | suppressed |
| Lidocaine | Lidocaine | 18 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 18 | suppressed |
| Verapamil Sr | Verapamil Hcl | 18 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 17 | suppressed |
| Cartia Xt | Diltiazem Hcl | 17 | suppressed |
| Gemfibrozil | Gemfibrozil | 17 | suppressed |
| Travoprost | Travoprost | 17 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 16 | 13 |
| Nitroglycerin | Nitroglycerin | 16 | suppressed |
| Timolol Maleate | Timolol Maleate | 16 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 15 | suppressed |
| Entacapone | Entacapone | 15 | suppressed |
| Fenofibrate | Fenofibrate | 15 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 15 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 15 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 15 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 15 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 15 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 15 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 14 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 14 | suppressed |
| Lubiprostone | Lubiprostone | 14 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 14 | suppressed |
| Sucralfate | Sucralfate | 14 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 13 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 13 | suppressed |
| Forteo | Teriparatide | 13 | suppressed |
| Glyburide | Glyburide | 13 | suppressed |
| Methadone Hcl | Methadone Hcl | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | 11 |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 13 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 13 | suppressed |
| Rybelsus | Semaglutide | 13 | suppressed |
| Trospium Chloride | Trospium Chloride | 13 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Mydayis | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Nabumetone | Nabumetone | 12 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 12 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 11 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Colchicine | Colchicine | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 11 | suppressed |
| Phenobarbital | Phenobarbital | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 11 | 11 |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Repatha Sureclick | Evolocumab | 11 | suppressed |
| Repatha Syringe | Evolocumab | 11 | suppressed |
| Verapamil Er Pm | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $840.59 · 13 records | Vanda Pharmaceuticals Inc. | ABRYSVO, AUSTEDO XR, COMIRNATY, FANAPT, Leqembi, NURTEC ODT, OTEZLA, PREVNAR 20, REPATHA, ZAVZPRET | 4 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Abrysvo play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Amgen Inc.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error